Notably, studies in animal models have shown that inhibiting or knocking out Caspase-1 can improve insulin sensitivity and glucose tolerance, emphasizing its role as a possible therapeutic target in T2D [4]. Here, CASP1 is linked to type 2 diabetes mellitus.